Kathleen E. Rodgers
Works at
Professor of medicine
Sources: reporter.nih.gov
Grants and prizes
R01, Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial, R01AG063826, 2019–2027, 11 Jul 2025
U01, IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease., U01AG063768, 2020–2026, 6 Jun 2023
Sources: reporter.nih.gov